The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

Dr. Oz, Administrator of the Centers for Medicare & Medicaid Services, joins MSNBC’s Ari Melber for an extended conversation ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

China has reported eight more H9N2 avian flu infections in people from four different areas, along with another H10N3 avian flu case in a resident of Guangxi province, the Hong Kong Centre for Health ...

The National Institute of Allergy and Infectious Diseases (NIAID) plans to initiate phase 1 clinical trial of Capricor's ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...